- Home
- BRY vs ZTEK Comparison
BRY vs ZTEK Comparison
Compare BRY & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRY
- ZTEK
- Stock Information
- Founded
- BRY 1909
- ZTEK 2008
- Country
- BRY United States
- ZTEK Canada
- Employees
- BRY N/A
- ZTEK N/A
- Industry
- BRY Oil & Gas Production
- ZTEK Major Chemicals
- Sector
- BRY Energy
- ZTEK Industrials
- Exchange
- BRY Nasdaq
- ZTEK Nasdaq
- Market Cap
- BRY 186.1M
- ZTEK 165.9M
- IPO Year
- BRY N/A
- ZTEK N/A
- Fundamental
- Price
- BRY $2.71
- ZTEK $1.49
- Analyst Decision
- BRY Buy
- ZTEK
- Analyst Count
- BRY 2
- ZTEK 0
- Target Price
- BRY $5.00
- ZTEK N/A
- AVG Volume (30 Days)
- BRY 1.0M
- ZTEK 44.7K
- Earning Date
- BRY 05-08-2025
- ZTEK 06-26-2025
- Dividend Yield
- BRY 4.43%
- ZTEK N/A
- EPS Growth
- BRY N/A
- ZTEK N/A
- EPS
- BRY N/A
- ZTEK N/A
- Revenue
- BRY $753,737,000.00
- ZTEK $44,936.00
- Revenue This Year
- BRY N/A
- ZTEK N/A
- Revenue Next Year
- BRY $5.00
- ZTEK N/A
- P/E Ratio
- BRY N/A
- ZTEK N/A
- Revenue Growth
- BRY N/A
- ZTEK 92.38
- 52 Week Low
- BRY $2.11
- ZTEK $0.50
- 52 Week High
- BRY $7.02
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- BRY 53.11
- ZTEK 49.24
- Support Level
- BRY $2.38
- ZTEK $1.52
- Resistance Level
- BRY $2.57
- ZTEK $1.62
- Average True Range (ATR)
- BRY 0.13
- ZTEK 0.10
- MACD
- BRY -0.01
- ZTEK -0.03
- Stochastic Oscillator
- BRY 41.25
- ZTEK 33.33
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.